Tau Therapeutics LLC and Xdynia LLC announced today that they have merged; the surviving entity in the merger, Tau Therapeutics LLC, has been renamed Cavion LLC.
The name “Cavion” reflects the combined company’s therapeutic approach of selectively inhibiting the Cav3 ion channel (T-type calcium channel).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”